Recent Finacing
Recent Raise
N30 Pharma is a Boulder-based biopharmaceutical company developing s‑nitrosothiol (SNO)-based therapeutics targeting GSNOR to treat respiratory, cardiovascular, and inflammatory diseases, advancing lead candidate N6022 toward human trials.
Focus Areas
Recent Investors
Total Raised
Funding round
Investor